Cardiac Coherence Combined With Personal Physical Activity in Patients With Cancer
APACCHE
Combination of Cardiac Coherence to Physical Activity
1 other identifier
interventional
80
1 country
1
Brief Summary
APACCHE (Adapted Physical Activity and Cardiac Coherence in HEmatologic patients) study investigates effects of heart rate variability biofeedback training, combined with classical adapted physical activity, on health-related quality of life in patients previously treated for hematologic malignancies. It is a prospective, randomized clinical trial from University Hospital of Reunion Island. The main objective is evaluated with QLQ-C30 survey score differences.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 23, 2017
CompletedFirst Posted
Study publicly available on registry
November 29, 2017
CompletedStudy Start
First participant enrolled
January 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 13, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
April 4, 2024
CompletedOctober 2, 2025
September 1, 2025
5.8 years
November 23, 2017
September 29, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Health-related quality of life
Health-related quality is assessed by the Quality of Life Questionnaire dedicated to cancer patients and including 30 items (QLQ-C30) developed by the European Organization for Research and Treatment of Cancer (EORTC). This questionnaire is a multimodal construct, typically including physical, emotional and psychological health issues; evaluated with the QLQ-C30 survey of the European Organization for Research and Treatment of Cancer. QLQ-C30 items are coded with the same response categories as items 6 to 28, namely "Not at all", "A little", "Quite a bit" and "Very much." Score ranges from 0 to 100, with higher score indicating higher levels of quality of life.
on week 12
Secondary Outcomes (3)
Fatigue improvement
through study completion: initially (T1), at 6 weeks (T2), 12 weeks (T3) and after at 24 weeks (T4) follow-up
Anxiety and depression improvement with Hospital Anxiety and Depression Scale (HADS) survey
through study completion: initially (T1), at 6 weeks (T2), 12 weeks (T3) and after at 24 weeks (T4) follow-up
Cardiac coherence improvement
through study completion: initially (T1), at 6 weeks (T2), 12 weeks (T3) and after at 24 weeks (T4) follow-up
Study Arms (2)
Cardiac Coherence
EXPERIMENTALPatients participate to Adapted physical activity sessions and to cardiac coherence sessions
Adapted Physical Activity
ACTIVE COMPARATORPatients only participate to Adapted physical activity sessions
Interventions
* 10 sessions of HRV-BF (45mn) weekly over 12 weeks. HRV-BF is a cognitive behavioural therapy consisting on stress management training based on breathing. We use the SYMBIOLINE PC software to record the heart rate variability biofeedback, with an infrared plethysmograph sensor. The sensor is put on the finger, and the patient's HRV pattern is displayed in real time. * 24 APA sessions (1.5h) bi-weekly over 12 weeks. Each session includes aerobic exercises (walk, step) and resistant exercises (muscular reinforcement). This program is built on previous cancer studies to make it effective.
\- 24 APA sessions (1.5h) bi-weekly over 12 weeks. Each session includes aerobic exercises (walk, step) and resistant exercises (muscular reinforcement). This program is built on previous cancer studies to make it effective.
Eligibility Criteria
You may qualify if:
- All patients, previously treated and in remission for an Hematologic malignancy, in whom APA is indicated.
- Adult patients aged 18-65 yo
- Followed at South University Hospital of La Réunion Island
- Previously treated for Hematologic Malignancy, and in Remission (complete or partial)
- months or less since last treatment
- Hemoglobin steady ≥ 90g/L
- In whom APA is prescribed
- Ability to give oral informed consent
- French understanding
You may not qualify if:
- With contraindication for APA
- Under anti-arhythmic or beta-blocker drugs
- Cardiac insufficiency (Left ventriculi Ejection Fraction less than 40%)
- Participation in another trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Hospitalier Universitaire de La Réunion
Saint-Pierre, 97410, Reunion
Related Publications (1)
Fournie C, Bouscaren N, Dalleau G, Lenclume V, Mohr C, Zunic P, Cabrera Q, Verkindt C. Adapted physical activity and cardiac coherence in hematologic patients (APACCHE): study protocol for a randomized controlled trial. BMC Sports Sci Med Rehabil. 2020 Mar 14;12:18. doi: 10.1186/s13102-020-00170-3. eCollection 2020.
PMID: 32190333DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Quentin CABRERA, MD
Centre Hospitalier Universitaire de La REUNION, France
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 23, 2017
First Posted
November 29, 2017
Study Start
January 1, 2018
Primary Completion
October 13, 2023
Study Completion
April 4, 2024
Last Updated
October 2, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share